| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |